What is the appropriate CPT (Current Procedural Terminology) code for an annual wellness visit for a 75-year-old male with a Packed Cell Volume (PCV) of 21 who received a flu shot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CPT Codes for Annual Wellness Visit with PCV21 and Flu Shot for 75-Year-Old Male

For a 75-year-old male receiving an annual wellness visit with a pneumococcal conjugate vaccine (PCV21) and flu shot, the appropriate CPT codes are G0438 or G0439 for the wellness visit, 90671 for PCV21, and 90662 for the high-dose influenza vaccine.

Annual Wellness Visit CPT Codes

  • G0438: Annual wellness visit, includes personalized prevention plan service, first visit 1
  • G0439: Annual wellness visit, includes personalized prevention plan service, subsequent visit 1

Vaccination CPT Codes

  • 90671: Pneumococcal conjugate vaccine, 21-valent (PCV21), for intramuscular use 2
  • 90662: Influenza virus vaccine (high-dose), for adults ≥65 years, for intramuscular use 2

Administration CPT Codes

  • G0008: Administration of influenza virus vaccine 2
  • G0009: Administration of pneumococcal vaccine 2

Vaccination Recommendations for 75-Year-Old Male

Pneumococcal Vaccination

  • For adults aged ≥65 years, a single dose of PCV21, PCV20, or PCV15 is recommended 2
  • If PCV15 is administered, a single dose of PPSV23 should be administered ≥1 year after the PCV15 dose 2
  • PCV21 contains eight pneumococcal serotypes not included in previously recommended pneumococcal vaccines but does not contain serotype 4 2
  • In certain western US populations with high percentages of serotype 4 IPD, this should be considered when selecting the appropriate vaccine 2

Influenza Vaccination

  • Annual influenza vaccination is recommended for all persons aged ≥6 months 2
  • For adults aged ≥65 years, high-dose influenza vaccine is preferred due to increased immunogenicity in this age group 2
  • Inactivated influenza vaccine (IIV) is recommended for immunocompromised patients, including those with low PCV (packed cell volume) 2

Special Considerations for Patient with Low PCV (21)

  • A PCV of 21 indicates significant anemia, which may affect immune response to vaccines 2
  • Patients with chronic medical conditions, including hematologic disorders, are at increased risk for pneumococcal disease 2
  • Inactivated vaccines (like PCV21 and inactivated influenza vaccines) are safe for patients with hematologic disorders 2

Coding Pitfalls to Avoid

  • Do not use the regular wellness visit codes (99381-99397) for Medicare patients; use the G-codes instead 1
  • Document medical necessity for both vaccines, especially in a patient with anemia (PCV 21) 1
  • Ensure separate administration codes (G0008, G0009) are used for each vaccine administered 2
  • For patients with severe anemia (PCV 21), document this as a chronic condition that supports the need for pneumococcal vaccination 2

Concomitant Administration

  • Pneumococcal and influenza vaccines can be safely administered during the same visit 3
  • Studies show no clinically significant interference in immune response when PCV and influenza vaccines are administered concomitantly 3, 4
  • Concomitant administration may improve vaccine uptake and compliance in older adults 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.